These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2804405)

  • 21. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity.
    Banerjee J; Ghosh P; Mitra S; Ghosh N; Bhattacharya S
    J Toxicol Environ Health; 1991 Jul; 33(3):283-90. PubMed ID: 1906943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased susceptibility to adult paraoxon exposure in mice neonatally exposed to nicotine.
    Ankarberg E; Fredriksson A; Eriksson P
    Toxicol Sci; 2004 Dec; 82(2):555-61. PubMed ID: 15356346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
    Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
    J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in mRNA and protein expression of glutamate transporters in rat hippocampus after paraoxon exposure.
    Mohammadi M; Zare Z; Allah-Moradi E; Vaezi N; Valadan R; Tehrani M
    Neurotoxicology; 2016 Dec; 57():251-257. PubMed ID: 27769869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
    Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
    Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different sensitivities to paraoxon of brain and serum cholinesterases from Pacu, an indigenous Brazilian fish.
    Bastos VL; Rossini A; Pinto LF; de Lima LM; Ceccarelli PS; Coelho MG; Bastos JC
    Bull Environ Contam Toxicol; 1998 Jan; 60(1):1-8. PubMed ID: 9484549
    [No Abstract]   [Full Text] [Related]  

  • 29. The protective effect of aldrin against the toxicity of organophosphate anticholinesterases.
    Triolo AJ; Coon JM
    J Pharmacol Exp Ther; 1966 Dec; 154(3):613-23. PubMed ID: 4288901
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of cholinergic drugs on neocortical EEG and flash-visual evoked potentials in the mouse.
    Tebano MT; Luzi M; Palazzesi S; Pomponi M; Loizzo A
    Neuropsychobiology; 1999; 40(1):47-56. PubMed ID: 10420101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicodynamic analysis of the combined cholinesterase inhibition by paraoxon and methamidophos in human whole blood.
    Bosgra S; van Eijkeren JC; van der Schans MJ; Langenberg JP; Slob W
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):9-15. PubMed ID: 19371630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors.
    Grauer E; Ben Nathan D; Lustig S; Kobiler D; Kapon J; Danenberg HD
    Life Sci; 2001 Jan; 68(9):985-90. PubMed ID: 11212873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
    Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
    J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of parameters of functions of respiratory and cardiovascular systems of different age rats under influence of small doses of cholinesterase inhibitor Phosphacol].
    Kuznetsov SV; Goncharov NV; Glashkina LM
    Zh Evol Biokhim Fiziol; 2005; 41(2):160-7. PubMed ID: 15909902
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.
    Liu J; Chakraborti T; Pope C
    Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The histochemical demonstration of end-plate esterase in maternal and fetal skeletal muscle after acute poisoning with cholinesterase inhibitors].
    Jonecko A
    Acta Histochem; 1965 Mar; 20(1):149-60. PubMed ID: 4953902
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of the route of exposure on the acute toxicity of cholinesterase inhibitors.
    Natoff IL
    Eur J Toxicol; 1970; 3(6):363-7. PubMed ID: 5520490
    [No Abstract]   [Full Text] [Related]  

  • 39. Metoclopramide protection of cholinesterase from paraoxon inhibition.
    Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
    Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cholinergic and noncholinergic mechanisms in the cardiorespiratory failure produced by N-methylcarbamate cholinesterase inhibitors in rabbits.
    Futagawa H; Kakinuma Y; Takahashi H
    Toxicol Appl Pharmacol; 2000 May; 165(1):27-36. PubMed ID: 10814550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.